Fate Therapeutics Inc (FATE) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.94x
Fate Therapeutics Inc (FATE) has a Cash Flow Reinvestment Rate of 0.94x as of June 2020, reinvesting $36.59 Million (capex $636.00K plus investments $35.96 Million) from operating cash flow of $38.84 Million. Explore Fate Therapeutics Inc cash conversion from operations to assess how effectively this company generates cash.
Reinvestment Rate
0.94x
(Capex + Investments) / Operating CF
Total Reinvested
$36.59 Million
Capex + Investments
Operating Cash Flow
$38.84 Million
USD
Capital Expenditures
$636.00K
USD
Annual Cash Flow Reinvestment Rate for Fate Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Fate Therapeutics Inc. For live market cap and broader valuation context, see FATE company net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow